Elevated inflammatory parameters are associated with lower platelet density in acute myocardial infarctions with ST-elevation

被引:35
作者
Järemo, P [1 ]
Hansson, G [1 ]
Nilsson, O [1 ]
机构
[1] Vrinnevisjukhuset, Dept Internal Med, Norrkoping, Sweden
关键词
interleukin; 6; myocardial infarction; neutrophil granulocytes; platelets; platelet density; P-selectin;
D O I
10.1016/S0049-3848(00)00366-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Platelets and granulocytes play important roles in coronary disorders. We therefore, investigated platelet and granulocyte alterations in myocardial infarctions (MIs). Patients and study design: A total of 36 individuals having MI with raised ST-segments who were receiving thrombolytic therapy were studied. Sampling was carried out after thrombolysis within 24 h after hospital admission. After 3 to 6 months of recovery, 25 patients were reinvestigated. At the infarction, peak platelet density was determined using a special designed computerised apparatus. In addition, we did counts on platelets, neutrophils and monocytes. Moreover, plasma levels of soluble P-selectin, myeloperoxidase and interleukin 6 were determined to estimate the degree of platelet, neutrophil and monocyte activation, respectively. Peak platelet density was analysed at the MI. All other parameters were determined at the acute event and at recovery. Results: At the MI, compared to the recovery, platelet counts were lower (P < .001). In addition, increased neutrophil counts (P < .001), elevated monocyte counts (P < .001), enhanced myeloperoxidase (P < .001) and interleukin 6 (P < .001) levels were demonstrated. We failed to show elevated soluble P-selectin. Compared to individuals with ST-segment elevations and low platelet density (<less than or equal to>1.058 kg/l), patients having peak platelet densities >1.058 kg/l displayed lower neutrophil counts (P < .01) and decreased interleukin 6 levels (P < .01). Furthermore, we demonstrate that individuals with higher inflammatory response at the MI had higher neutrophil (r = .6; P < .01) and higher monocyte counts (r = .6; P < .001) at recovery. Conclusion: We conclude that MI is associated with an inflammatory response. However, a subgroup of patients having MI with ST-elevations and low peak platelet density was identified. Compared to subjects with higher platelet density, they had more severe inflammatory characteristics. The differences persisted during recovery. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:471 / 478
页数:8
相关论文
共 27 条
[1]   RELATION OF FIBRINOGEN TO PRESENCE AND SEVERITY OF CORONARY-ARTERY DISEASE IS INDEPENDENT OF OTHER COEXISTING HEART-DISEASE [J].
BOLIBAR, I ;
KIENAST, J ;
THOMPSON, SG ;
MATTHIAS, R ;
NIESSNER, H ;
FECHTRUP, C .
AMERICAN HEART JOURNAL, 1993, 125 (06) :1601-1605
[2]   A NOVEL BIOLOGICAL EFFECT OF PLATELET-FACTOR-4 (PF4) - ENHANCEMENT OF LPS-INDUCED TISSUE FACTOR ACTIVITY IN MONOCYTES [J].
ENGSTAD, CS ;
LIA, K ;
REKDAL, O ;
OLSEN, JO ;
OSTERUD, B .
JOURNAL OF LEUKOCYTE BIOLOGY, 1995, 58 (05) :575-581
[3]   LEUKOCYTES AND THE RISK OF ISCHEMIC DISEASES [J].
ERNST, E ;
HAMMERSCHMIDT, DE ;
BAGGE, U ;
MATRAI, A ;
DORMANDY, JA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (17) :2318-2324
[4]   INSIGHTS INTO THE PATHOGENESIS OF ACUTE ISCHEMIC SYNDROMES [J].
FUSTER, V ;
BADIMON, L ;
COHEN, M ;
AMBROSE, JA ;
BADIMON, JJ ;
CHESEBRO, J .
CIRCULATION, 1988, 77 (06) :1213-1220
[5]  
GROSCURTH P, 1988, EUR J HAEMATOL, V41, P37
[6]   GRANULOCYTES ENHANCE LPS-INDUCED TISSUE FACTOR ACTIVITY IN MONOCYTES VIA AN INTERACTION WITH PLATELETS [J].
HALVORSEN, H ;
OLSEN, JO ;
OSTERUD, B .
JOURNAL OF LEUKOCYTE BIOLOGY, 1993, 54 (04) :275-282
[7]   Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris -: Results from the APSIS study [J].
Held, C ;
Hjemdahl, P ;
Wallén, NH ;
Björkander, I ;
Forslund, L ;
Wiman, B ;
Rehnqvist, N .
ATHEROSCLEROSIS, 2000, 148 (01) :179-188
[8]   FINAL REPORT ON THE ASPIRIN COMPONENT OF THE ONGOING PHYSICIANS HEALTH STUDY [J].
HENNEKENS, CH .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (03) :129-135
[9]  
HIRANO T, 1992, CLIN IMMUNOL IMMUNOP, V62, P60
[10]  
HIRSH P D, 1981, New England Journal of Medicine, V304, P685, DOI 10.1056/NEJM198103193041201